Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating NT 201 versus placebo for chronic troublesome drooling in neurological disorders and intellectual disability; results complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Intellectual Disability
• Stroke
• Traumatic Brain Injury
• Troublesome Sialorrhea

Drugs mentioned

• NT 201

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Chronic Troublesome Sialorrhea, Cerebral Palsy | Phase 3 | Status: COMPLETED | Results posted: 2021-01-20